Alcami has agreed to sell its pre-clinical and early stage API facility in Weert, Netherlands, to MercachemSyncom. Terms were not disclosed.
Private equity investor Advent International has acquired Industria Chimica Emiliana (ICE) after 40 years of ownership by the Bortoli family, who developed the first laboratory bile acids.
UK-based biopharmaceuticals producer Mallinckrodt has agreed to sell is CDMO subsidiary BioVectra to HIG Capital, a private equity firm.
Cambrex has signed a definitive agreement to be acquired by an affiliate of private equity firm Permira, which has $48 billion of committed capital in its portfolio, covering healthcare among four other sectors.
Onyx Scientific has revealed that it has been engaging with the UK Medicines & Healthcare Products Regulatory Agency (MHRA) with a view to securing a commercial API licence by the end of 2019.
Belgian CDMO Ardena has launched Ardena LSI, which it describes as “a new business arm dedicated to the sale of chemical ingredients and intermediates for the life science industry”.